SG Americas Securities
TAK icon

SG Americas Securities’s Takeda Pharmaceutical TAK Stock Holding History

SG Americas Securities’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-249,900
Closed -$45K – 3224
2021
Q1 		$45K Buy
+249,900
New +$4.5M ﹤0.01% 3169

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

SG Americas Securities's TAK Position: Q2 2026 in Review

SG Americas Securities held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 7,065 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #3064.

SG Americas Securities first reported a position in TAK in Q1 2019 and has held it in 23 quarters since. The position peaked at $610K in Q1 2021. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • SG Americas Securities held 7,065 shares of Takeda Pharmaceutical worth $113K as of Q2 2026.
  • SG Americas Securities left its Takeda Pharmaceutical share count unchanged in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3064 holding.
  • SG Americas Securities first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 23 quarters since.
  • SG Americas Securities's Takeda Pharmaceutical position peaked at $610K in Q1 2021.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.